Summary & Overview
HCPCS S5570: Insulin Delivery Device, Disposable Pen (1.5 ml)
HCPCS Level II code S5570 denotes a disposable insulin delivery pen, including the insulin, with a 1.5 ml capacity. This supply-oriented code is important for national diabetes care because disposable insulin pens are widely used for insulin-dependent patients to improve dosing accuracy, adherence, and portability. Coverage and coding for these devices affect pharmacy benefit management, medical supply reimbursement, and patient out-of-pocket costs.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of reimbursement benchmarks, typical coverage patterns across major payers, and clinical context on how this device integrates into outpatient diabetes management. The publication outlines common billing considerations for service lines that handle diabetes supplies and highlights payer policy themes that influence access and billing practices.
This summary provides practical reference material for billing, coding, and revenue teams, as well as clinicians coordinating device provision. Data not available in the input is noted where applicable in the full publication.
Billing Code Overview
HCPCS Level II code S5570 describes an insulin delivery device, disposable pen (including insulin); 1.5 ml size. This code represents a single-use insulin pen system packaged with insulin intended for subcutaneous administration by patients or caregivers.
Service Type: Durable medical/supplies for diabetes management
Typical Site of Service: Outpatient settings, pharmacies, clinics, and patient self-administration at home
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with type 2 diabetes mellitus requires initiation of insulin therapy for persistent hyperglycemia despite optimized oral agents. The clinic visit is conducted in an outpatient endocrinology or primary care office. The clinician assesses blood glucose logs, reviews hemoglobin A1c, and decides to start a disposable insulin pen device containing 1.5 ml of insulin for patient self-administration. The clinic nurse provides device education, demonstrates injection technique, reviews storage and disposal, and supplies the disposable pen to the patient. Typical workflow steps include: patient intake and vitals, medication reconciliation, physician or advanced practice clinician assessment, device selection and dispensing, patient education and demonstration, documentation of lot number and manufacturer on the medication administration record, and billing for the device using the HCPCS Level II code S5570 if applicable to the payer. Typical site of service: outpatient clinic, physician office, or home health visit when delivered with home services. Typical patient scenario: adult with type 1 or type 2 diabetes requiring outpatient initiation or change of insulin delivery modality to a disposable pen (1.5 ml).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / unmodified service | When no special modifier applies to the supply of the disposable insulin pen |
52 | Reduced services | If a reduced or partial supply is furnished compared with usual practice |
53 | Discontinued procedure | If the supply/dispensing was planned but discontinued before completion |
62 | Two surgeons | Rare for device supply; used when two clinicians of different specialties share responsibility for the visit that results in device provision |
78 | Return to operating room | Not typically used for this supply; use only if related to a procedure requiring reoperation that also includes device provision |
80 | Assistant surgeon | Not typical for device supply; used when an assistant surgeon participated in a procedure tied to device provision |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for independent delivery | When an eligible non-physician practitioner furnishes the device under their own NPI and state scope of practice |
NU | New equipment | To indicate new disposable device supplied to the patient (versus replacement or repair) |
QK | Medical direction by a physician; more than four concurrent anesthesia cases | Not routinely applicable; include only if regulatory billing rules require alongside anesthesia-related services |
QX | CRNA service with medical direction | Not routinely applicable; include only when tied to anesthesia services associated with device use |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207RP1000X | Internal Medicine | Primary care clinicians who initiate insulin and dispense pens in the office |
207RI0010X | Endocrinology` | Specialists who manage complex diabetes and select insulin delivery devices |
363L00000X | Nurse Practitioner | Advanced practice providers who educate and dispense devices in outpatient settings |
363A00000X | Physician Assistant | Midlevel providers who manage diabetes treatment and supply pens |
334500000X | Certified Diabetes Educator | Clinicians focused on patient education and device training |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
E11.9 | Type 2 diabetes mellitus without complications | Common indication for initiating or adjusting insulin delivered via a disposable pen |
E11.65 | Type 2 diabetes mellitus with hyperglycemia | Active hyperglycemia prompting initiation or intensification of insulin therapy with a disposable pen |
E10.9 | Type 1 diabetes mellitus without complications | Insulin-dependent diabetes frequently managed with insulin pens for outpatient self-administration |
E11.21 | Type 2 diabetes mellitus with diabetic nephropathy | Comorbid condition requiring careful insulin dosing and often prompting use of user-friendly pen devices |
E11.69 | Type 2 diabetes mellitus with other specified complications | Complex diabetes cases where insulin pen selection is part of comprehensive management |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Common E/M visit during which the decision to dispense a disposable insulin pen is made and documented |
99406 | Smoking and tobacco use cessation counseling visit, intermediate, 3-10 minutes | May be performed during the same encounter when counseling on risk modification for patients with diabetes |
96127 | Brief emotional/behavioral assessment (e.g., depression screener) | Screening for depression or distress that can affect diabetes self-management; often done in the same visit |
98960 | Education and training for patient self-management by a qualified, nonphysician health care professional, face-to-face; individual, per 30 minutes | Diabetes self-management training that can accompany instruction on using a disposable insulin pen |
G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Medicare-covered diabetes education services that may be provided alongside device dispensing |